Literature DB >> 27856529

Remote multifocal bleeding points producing a Sylvian subpial hematoma during endovascular coiling of an acutely ruptured cerebral aneurysm.

Christopher Alan Hilditch1, Hemant Sonwalkar1, Siddhartha Wuppalapati1.   

Abstract

Subpial hematoma is a rare type of intracranial hemorrhage with a poor prognosis. A new mechanism to explain subpial Sylvian hematoma formation in acute post-aneurysmal subarachnoid hemorrhage (SAH) was observed during coiling of a posterior communicating artery aneurysm. Multiple small bleeding points from pial branches of the left middle cerebral artery, which were remote from the ruptured aneurysm, were observed on conventional angiography. This bleeding led to the formation of a large expanding subpial Sylvian hematoma. Similar observations have been recently demonstrated on 4D CT angiography (4D CTA). We present a case that adds evidence to the literature in support of a new mechanism of subpial hematoma formation in the setting of acute SAH. This may advocate the early use of 4D CTA and conveys a poor prognosis, which might influence treatment decisions. 2016 BMJ Publishing Group Ltd.

Entities:  

Keywords:  Aneurysm; Coil; Hemorrhage; Subarachnoid

Mesh:

Year:  2016        PMID: 27856529      PMCID: PMC5129161          DOI: 10.1136/bcr-2016-012715

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Intraparenchymal and intrasylvian haematomas secondary to ruptured middle cerebral artery aneurysms: prognostic factors and therapeutic considerations.

Authors:  Y Yoshimoto; S Wakai; A Satoh; Y Hirose
Journal:  Br J Neurosurg       Date:  1999-02       Impact factor: 1.596

2.  Subpial Hematoma and Extravasation in the Interhemispheric Fissure with Subarachnoid Hemorrhage.

Authors:  Kazufumi Suzuki; Go Matsuoka; Kayoko Abe; Yoshikazu Okada; Shuji Sakai
Journal:  Neuroradiol J       Date:  2015-05-11

Review 3.  4D-CTA in neurovascular disease: a review.

Authors:  H G J Kortman; E J Smit; M T H Oei; R Manniesing; M Prokop; F J A Meijer
Journal:  AJNR Am J Neuroradiol       Date:  2014-10-29       Impact factor: 3.825

Review 4.  Cerebrovascular inflammation following subarachnoid hemorrhage.

Authors:  Richard Sercombe; Yves R Tran Dinh; Philippe Gomis
Journal:  Jpn J Pharmacol       Date:  2002-03

5.  A series of patients with subpial hemorrhage: clinical manifestation, neuroradiological presentation and therapeutic implications.

Authors:  Patrick Roth; Caroline Happold; Günter Eisele; Thomas Nägele; Michael Weller; Andreas R Luft
Journal:  J Neurol       Date:  2008-05-07       Impact factor: 4.849

6.  Origin of sylvian hematoma in patients with subarachnoid hemorrhage: findings of extravasation on multiphase contrast-enhanced computed tomography.

Authors:  Kazufumi Suzuki; Eiko Ueno; Hidetoshi Kasuya
Journal:  World Neurosurg       Date:  2013-02-08       Impact factor: 2.104

7.  Proposed use of prophylactic decompressive craniectomy in poor-grade aneurysmal subarachnoid hemorrhage patients presenting with associated large sylvian hematomas.

Authors:  Edward R Smith; Bob S Carter; Christopher S Ogilvy
Journal:  Neurosurgery       Date:  2002-07       Impact factor: 4.654

8.  Intracerebral hematoma in patients with ruptured cerebral aneurysms.

Authors:  Y Tokuda; T Inagawa; Y Katoh; K Kumano; N Ohbayashi; H Yoshioka
Journal:  Surg Neurol       Date:  1995-03

9.  Emerging sylvian subpial hematoma after the repair of the ruptured anterior cerebral artery aneurysm with interhemispheric approach: case report.

Authors:  Noriaki Minami; Toshikazu Kimura; Yasumitsu Ichikawa; Akio Morita
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-11-20       Impact factor: 1.742

  9 in total
  1 in total

1.  Delayed Progressive Mass Effect After Secured Ruptured Middle Cerebral Artery Aneurysm: Risk Factors and Outcomes.

Authors:  Ying-Ching Li; Ching-Chang Chen; Chun-Ting Chen; Po-Hsun Tu; Mun-Chun Yeap; Yi-Ming Wu; Zhuo-Hao Liu; Ting-Wei Chang; Ya-Jui Lin; Tai-Wei Erich Wu; Po-Chuan Hsieh
Journal:  Front Surg       Date:  2022-05-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.